COMPLEMENT GENETICS IN RELATION TO HLALACHMANN PJ; HOBART MJ.1978; BRIT. MED. BULL.; GBR; DA. 1978; VOL. 34; NO 3; PP. 247-252; BIBL. 60 REF.Article

A SECOND CASE OF HUMAN C3B INHIBITOR (KAF) DEFICIENCY.THOMPSON RA; LACHMANN PJ.1977; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1977; VOL. 27; NO 1; PP. 23-29; BIBL. 20 REF.Article

COMPLEMENT AND CELL MEMBRANES.MCCONNELL I; LACHMANN PJ.1976; TRANSPLANT. REV.; DENM.; DA. 1976; VOL. 32; PP. 72-92; BIBL. 2 P.Article

THIOL ANTIDOTE TO INORGANIC MERCURY TOXICITY WITH AN UNCHARACTERISTIC MECHANISMGIROUX E; LACHMANN PJ.1982; TOXICOLOGY AND APPLIED PHARMACOLOGY; ISSN 0041-008X; USA; DA. 1982; VOL. 67; NO 2; PP. 178-183; BIBL. 27 REF.Article

NOVEL CLEAVAGE PRODUCTS OF THE THIRD COMPONENT OF HUMAN COMPLEMENTHARRISON RA; LACHMANN PJ.1980; MOL. IMMUNOL.; GBR; DA. 1980; VOL. 17; NO 2; PP. 219-228; BIBL. 31 REF.Article

CONGLUTININ BINDING POLYETHYLENE GLYCOL PRECIPITATION ASSAY FOR IMMUNE COMPLEXESMACANOVIC M; LACHMANN PJ.1979; CLIN. EXPER. IMMUNOL.; GBR; DA. 1979; VOL. 38; NO 2; PP. 274-283; BIBL. 13 REF.Article

THE GENETICS OF THE COMPLEMENT SYSTEMLACHMANN PJ; HOBART MJ.1979; CIBA FOUND. SYMP.; NLD; DA. 1979; NO 66; PP. 231-250; BIBL. DISSEM.Conference Paper

HAEMOLYTIC ASSAYS IN AGAROSE PLATES FOR COMPONENTS OF THE CLASSICAL COMPLEMENT PATHWAY: INTERFERENCE BY THE ALTERNATIVE PATHWAY.MARTIN A; LACHMANN PJ.1977; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1977; VOL. 27; NO 1; PP. 13-22; BIBL. 12 REF.Article

THE PHYSIOLOGICAL BREAKDOWN OF THE THIRD COMPONENT OF HUMAN COMPLEMENTHARRISON RA; LACHMANN PJ.1980; MOL. IMMUNOL.; GBR; DA. 1980; VOL. 17; NO 1; PP. 9-20; BIBL. 44 REF.Article

AN IMPROVED PURIFICATION PROCEDURE FOR THE THIRD COMPONENT OF COMPLEMENT AND BETA 1H GLOBULIN FROM HUMAN SERUMHARRISON RA; LACHMANN PJ.1979; MOL. IMMUNOL.; GBR; DA. 1979; VOL. 16; NO 10; PP. 767-776; BIBL. 46 REF.Article

THE FAILURE TO SHOW A NECESSARY ROLE FOR C3 IN THE IN VITRO ANTIBODY RESPONSEWALDMANN H; LACHMANN PJ.1975; EUROP. J. IMMUNOL.; GERM.; DA. 1975; VOL. 5; NO 3; PP. 185-193; BIBL. 40REF.Article

IN VITRO MODULATION OF VIRAL CELL SURFACE GLYCOPROTEINS BY ANTI-VIRAL ANTIBODY IN THE PRESENCE OF COMPLEMENTGORMAN NT; LACHMANN PJ.1982; CLIN. EXP. IMMUNOL.; ISSN 0009-9104; GBR; DA. 1982; VOL. 50; NO 3; PP. 507-514; BIBL. 21 REF.Article

INTESTINAL GLYCOPROTEIN ACTIVATES THE ALTERNATIVE COMPLEMENT PATHWAY BY REACTING WITH FACTOR HWINSNES R; LACHMANN PJ.1982; SCAND. J. IMMUNOL.; ISSN 0300-9475; NOR; DA. 1982; VOL. 15; NO 4; PP. 371-378; BIBL. 20 REF.Article

COMPLEMENT RECEPTORS AND CELL ASSOCIATED COMPLEMENT COMPONENTS.MCCONNELL I; LACHMANN PJ.1977; IMMUNOL. COMMUNIC.; U.S.A.; DA. 1977; VOL. 6; NO 2; PP. 111-132; BIBL. 3 P.Article

ALLOTYPES OF COMPLEMENT COMPONENTS IN MAN.HOBART MJ; LACHMANN PJ.1976; TRANSPLANT. REV.; DENM.; DA. 1976; VOL. 32; PP. 26-42; BIBL. 3 P.Article

REACTION MECHANISM OF THE ALTERNATIVE PATHWAY OF COMPLEMENT FIXATION = MECANISME DE REACTION DE LA VOIE ALTERNEE DE LA FIXATION DU COMPLEMENTLACHMANN PJ; NICOL P.1973; LANCET; G.B.; DA. 1973; NO 7801; PP. 465-467; BIBL. 9REF.Serial Issue

FACTOR B OF THE ALTERNATIVE COMPLEMENT PATHWAY ON HUMAN LYMPHOCYTES.HALBWACHS L; LACHMANN PJ.1976; SCAND. J. IMMUNOL.; NORWAY; DA. 1976; VOL. 5; NO 6-7; PP. 697-704; BIBL. 31 REF.Article

THE INFLUENCE OF C3B INACTIVATOR (KAF) CONCENTRATION ON THE ABILITY OF SERUM TO SUPPORT COMPLEMENT ACTIVATIONLACHMANN PJ; HALBWACHS L.1975; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1975; VOL. 21; NO 1; PP. 109-114; BIBL. 10REF.Article

IN VIVO DIMINUTION BY CHELATORS OF SNAKE VENOM-PROVOKED HEMORRHAGE AND IN VITRO INHIBITION OF PROTEOLYTIC ACTIVITYGIROUX E; LACHMANN PJ.1981; TOXICON (OXF.); ISSN 0041-0101; GBR; DA. 1981; VOL. 19; NO 4; PP. 481-492; BIBL. 18 REF.Article

THE DETECTION AND CHARACTERIZATION OF A MEMBRANE PROTEIN WITH FACTOR B-LIKE ACTIVITY ON HUMAN LYMPHOID CELLSWOO P; LACHMANN PJ.1981; IMMUNOLOGY; ISSN 0019-2805; GBR; DA. 1981; VOL. 44; NO 3; PP. 629-639; BIBL. 12 REF.Article

IGG SYNTHESIS WITHIN THE BRAIN IN MULTIPLE SCLEROSIS AND SUBACUTE SCLEROSING PANENCEPHALITISEWAN PW; LACHMANN PJ.1979; CLIN. EXPER. IMMUNOL.; GBR; DA. 1979; VOL. 35; NO 2; PP. 227-235; BIBL. 1 P.Article

COUPLING PPD TO TUMOUR CELLS ENHANCES THEIR ANTIGENICITY IN BCG-PRIMED MICE.LACHMANN PJ; SIKORA K.1978; NATURE; G.B.; DA. 1978; VOL. 271; NO 5644; PP. 463-464; BIBL. 7 REF.Article

DEMONSTRATION OF T-CELL AND K-CELL CYTOTOXICITY AGAINST MEASLES-INFECTED CELLS IN NORMAL SUBJECTS, MULTIPLE SCLEROSIS AND SUBACUTE SCLEROSING PANENCEPHALITIS.EWAN PW; LACHMANN PJ.1977; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1977; VOL. 30; NO 1; PP. 22-31; BIBL. 36 REF.Article

THE FRACTIONATION OF ANTIGEN-DEPENDENT MACROPHAGE MIGRATION INHIBITION AND MACROPHAGE ACTIVATION FACTORS FROM LYMPH DRAINING A TUBERCULIN REACTIONLOWE DM; LACHMANN PJ.1974; SCAND. J. IMMUNOL.; SWED.; DA. 1974; VOL. 3; NO 4; PP. 423-432; BIBL. 20REF.Article

THE ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION. THE ROLE OF C3 AND ITS INACTIVATOR (KAF)NICOL PAE; LACHMANN PJ.1973; IMMUNOLOGY; G.B.; DA. 1973; VOL. 24; NO 2; PP. 259-275; BIBL. 1 P.1/2Serial Issue